Liquid Chromatography – Products

To support today’s modern laboratories, Thermo Fisher Scientific is introducing several new columns to meet researchers’ analytical, efficiency, and scalability needs at HPLC 2024, taking place in Denver, CO from July 20 – 25.

Through short instructional videos, this compendium explores the features and analytical capabilities of different LC-MS systems each designed to meet your needs for more efficient screening.

This study aims to assess the benefits of migrating and modernizing reversed-phase liquid chromatography (RPLC) methods with the Alliance iS Bio HPLC System with test cases of insulin analogs and glucagon-like peptide (GLP-1) drug substances.

In this application note, we’ll assess the benefits of the Alliance iS Bio HPLC System by migrating and modernizing a compendial SEC method outlined in the United States Pharmacopeia (USP) General Chapter <129>.

In this study, we evaluate the Alliance iS Bio HPLC System in a routine QC testing environment for biopharmaceuticals.

This example will demonstrate the ease and added compliance provided in using embedded software tools in the replication or transfer of an existing method to the Alliance iS HPLC System.

In this application note, a global interlaboratory method transfer of a USP organic impurities method was conducted across eight sites with the Alliance iS HPLC System.

This study demonstrates the use of AOAC 2015.17 for the analysis of ashwagandha root extracts and dietary supplements using the Alliance iS HPLC System.

In this work, a HILIC method for the analysis of active pharmaceutical ingredient (API), ribavirin, and related compounds was scaled from a 1.7 μm (2.1 x 50 mm) column to 2.5 μm (3.0 x 75 mm), and 3.5 μm (4.6 x 100 mm) columns with equivalent chemistry.

In this application note, we will demonstrate how the Alliance iS HPLC System operated over forty days with consistent, accurate results of the USP Fluconazole Organic Impurities method.